ORIGINAL RESEARCH
Published on 12 Nov 2025
Pharmacovigilance study of the frequency of gastrointestinal ulceration reports associated with immune checkpoint inhibitors: insights from the FDA adverse event reporting system
doi 10.3389/fphar.2025.1682259
- 324 views
